Abstract
The spatiotemporal-specific gene expression in different cell types from a common genome of a multicellular organism is the basis of cellular function, tissue development, and homeostasis of the multicellular life. Dysregulation of the spatiotemporal gene expression pattern often leads to disease pathogenesis. Enhancers define distinct cell identities by determining the precise spatiotemporal patterns of gene expression during development. Enhancers can also respond to diverse environmental signals including different nutritional status to fine-tune the cellular functional demands. Thus, unraveling the intricate regulatory process of enhancer in governing gene expression has become a major thrust of the biological field to decipher developmental process and disease pathogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 3C:
-
Chromosome conformation capture
- AF9:
-
ALL1-fused gene from chromosome 9
- AFF:
-
AF4/FMR2
- AML:
-
Acute myeloid leukemia
- BET:
-
Bromodomain and extra-terminal
- BRD4:
-
Bromodomain-containing protein 4
- Cas9:
-
CRISPR-associated protein-9 nuclease
- CBP:
-
CREB-binding protein
- CBS:
-
CTCF-binding site
- CDK9:
-
Cyclin-dependent kinase 9
- CdLS:
-
Cornelia de Lange syndrome
- CML:
-
Chronic myelogenous leukemia
- COMPASS:
-
Complex proteins associated with set1
- CREB:
-
Cyclic AMP-responsive element-binding protein
- CRISPR:
-
Clustered regularly interspaced short palindromic repeat
- CTCF:
-
CCCTC-binding factor
- CTD:
-
C-terminal domain
- DHS:
-
DNase I hypersensitive site
- DIPG:
-
Diffuse intrinsic pontine glioma
- DRB:
-
5,6-Dichloro-1-ß-D-ribofuranosylbenzimidazole
- DSIF:
-
DRB-sensitivity-inducing factor
- E2:
-
17β-estradiol
- EGF:
-
Epidermal growth factor
- ELL:
-
Eleven-nineteen Lys-rich leukemia
- ENCODE:
-
Encyclopedia of DNA Elements
- ENL:
-
Eleven-nineteen leukemia
- eRNA:
-
Enhancer RNA
- ERα:
-
Estrogen receptor-α
- EZH2:
-
Enhancer of zeste homolog 2
- Fox:
-
Forkhead box
- GTF:
-
General transcription factor
- GWAS:
-
Genome-wide association study
- H3K27ac:
-
Histone H3 lysine 27 acetylation
- H3K27me3:
-
Histone H3 lysine 27 trimethylation
- H3K4me1:
-
Histone H3 lysine 4 monomethylation
- H3K4me3:
-
Histone H3 lysine 4 trimethylation
- HEXIM1:
-
Hexamethylene bisacetamide inducible 1
- HEXIM2:
-
Hexamethylene bisacetamide inducible 2
- HGP:
-
Human Genome Project
- HL:
-
Hodgkin lymphoma
- ICGC:
-
International Cancer Genome Consortium
- IEG:
-
Immediate early gene
- JmjC:
-
Jumonji C
- LNA:
-
Locked nucleic acid antisense oligonucleotide
- LSD1:
-
Lysine (K)-specific demethylase 1A
- MLL:
-
Mixed lineage leukemia
- modENCODE:
-
Model Organism Encyclopedia of DNA Elements
- mRNA:
-
Messenger RNA
- NELF:
-
Negative elongation factor
- NFR:
-
Nucleosome-free region
- NGS:
-
Next-generation sequencing
- NHL:
-
Non-Hodgkin lymphoma
- nt:
-
Nucleotide
- NuRD:
-
Nucleosome remodeling and histone deacetylation
- PcG:
-
Polycomb group
- PIC:
-
Pre-initiation complex
- PPARγ:
-
Peroxisome proliferator-activated receptor gamma
- PRC2:
-
Polycomb repressive complex 2
- P-TEFb:
-
Positive transcription elongation factor b
- RNA Pol II:
-
RNA polymerase II
- RRM:
-
RNA recognition motif
- rRNA:
-
Ribosomal RNA
- SEC:
-
Super elongation complex
- SEC-L2:
-
SEC-like 2
- SEC-L3:
-
SEC-like 3
- siRNA:
-
Small interfering RNA
- SNP:
-
Single nucleotide polymorphism
- snRNP:
-
Small nuclear ribonucleoprotein particle
- SV40:
-
Simian virus 40
- TAD:
-
Topologically associating domain
- T-ALL:
-
T-cell acute lymphoblastic leukemia
- TCGA:
-
The Cancer Genome Atlas
- TPR:
-
Tetratricopeptide-repeats
- Trr:
-
Trithorax related
- TrxG:
-
Trithorax group
- TSS:
-
Transcription start site
- TZD:
-
Thiazolidinedione
- UTX:
-
Ubiquitously transcribed X chromosome tetratricopeptide repeat protein
References
Adelman K, Lis JT (2012) Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 13(10):720–731
Arner E, Daub CO et al (2015) Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science 347(6225):1010–1014
Banerji J, Rusconi S et al (1981) Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 27(2 Pt 1):299–308
Banerji J, Olson L et al (1983) A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33(3):729–740
Buenrostro JD, Giresi PG et al (2013) Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods 10(12):1213–1218
Calo E, Wysocka J (2013) Modification of enhancer chromatin: what, how, and why? Mol Cell 49(5):825–837
Chen K, Chen Z et al (2015) Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes. Nat Genet 47(10):1149–1157
Creyghton MP, Cheng AW et al (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 107(50):21931–21936
de Wit E, Vos ES et al (2015) CTCF binding polarity determines chromatin looping. Mol Cell 60(4):676–684
Di Croce L, Helin K (2013) Transcriptional regulation by Polycomb group proteins. Nat Struct Mol Biol 20(10):1147–1155
Dixon JR, Selvaraj S et al (2012) Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485(7398):376–380
Dorsett D (2011) Cohesin: genomic insights into controlling gene transcription and development. Curr Opin Genet Dev 21(2):199–206
Filippakopoulos P, Knapp S (2014) Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov 13(5):337–356
Gardini A, Baillat D et al (2014) Integrator regulates transcriptional initiation and pause release following activation. Mol Cell 56(1):128–139
Gui Y, Guo G et al (2011) Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43(9):875–878
Guo Y, Xu Q et al (2015) CRISPR inversion of CTCF sites alters genome topology and enhancer/promoter function. Cell 162(4):900–910
Haakonsson AK, Stahl Madsen M et al (2013) Acute genome-wide effects of rosiglitazone on PPARgamma transcriptional networks in adipocytes. Mol Endocrinol 27(9):1536–1549
Hannenhalli S, Kaestner KH (2009) The evolution of fox genes and their role in development and disease. Nat Rev Genet 10(4):233–240
Heintzman ND, Stuart RK et al (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39(3):311–318
Herz HM, Mohan M et al (2012) Enhancer-associated H3K4 monomethylation by Trithorax-related, the drosophila homolog of mammalian Mll3/Mll4. Genes Dev 26(23):2604–2620
Hu D, Gao X et al (2013) The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol Cell Biol 33(23):4745–4754
Hudson TJ, Anderson W et al (2010) International network of cancer genome projects. Nature 464(7291):993–998
Izumi K, Nakato R et al (2015) Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin. Nat Genet 47(4):338–344
Jin Q, Yu LR et al (2011) Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 30(2):249–262
Kagey MH, Newman JJ et al (2010) Mediator and cohesin connect gene expression and chromatin architecture. Nature 467(7314):430–435
Kaikkonen MU, Spann NJ et al (2013) Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell 51(3):310–325
Kim TK, Hemberg M et al (2010) Widespread transcription at neuronal activity-regulated enhancers. Nature 465(7295):182–187
Lai F, Gardini A et al (2015) Integrator mediates the biogenesis of enhancer RNAs. Nature 525(7569):399–403
Lee JE, Wang C et al (2013) H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. elife 2:e01503
Levine M (2011) Paused RNA polymerase II as a developmental checkpoint. Cell 145(4):502–511
Lewis PW, Muller MM et al (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340(6134):857–861
Li G, Ruan X et al (2012) Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148(1–2):84–98
Li W, Notani D et al (2013) Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498(7455):516–520
Lieberman-Aiden E, van Berkum NL et al (2009) Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326(5950):289–293
Lin C, Smith ER et al (2010) AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell 37(3):429–437
Lin C, Garrett AS et al (2011) Dynamic transcriptional events in embryonic stem cells mediated by the super elongation complex (SEC). Genes Dev 25(14):1486–1498
Lin C, Garruss AS et al (2013) The RNA pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation. Cell 152(1–2):144–156
Luo Z, Lin C (2016) Enhancer, epigenetics, and human disease. Curr Opin Genet Dev 36:27–33
Luo Z, Lin C et al (2012a) The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output. Mol Cell Biol 32(13):2608–2617
Luo Z, Lin C et al (2012b) The super elongation complex (SEC) family in transcriptional control. Nat Rev Mol Cell Biol 13(9):543–547
Mannini L, Lamaze FC et al (2015) Mutant cohesin affects RNA polymerase II regulation in Cornelia de Lange syndrome. Sci Rep 5:16803
Maurano MT, Humbert R et al (2012) Systematic localization of common disease-associated variation in regulatory DNA. Science 337(6099):1190–1195
Mendenhall EM, Williamson KE et al (2013) Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol 31(12):1133–1136
Morin RD, Johnson NA et al (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42(2):181–185
Morin RD, Mendez-Lago M et al (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476(7360):298–303
Ntziachristos P, Tsirigos A et al (2014) Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature 514(7523):513–517
Pasquali L, Gaulton KJ et al (2014) Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat Genet 46(2):136–143
Pekowska A, Benoukraf T et al (2011) H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J 30(20):4198–4210
Piunti A, Shilatifard A (2016) Epigenetic balance of gene expression by Polycomb and COMPASS families. Science 352(6290):aad9780
Qi W, Chan H et al (2012) Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci USA 109(52):21360–21365
Rada-Iglesias A, Bajpai R et al (2011) A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470(7333):279–283
Schaukowitch K, Joo JY et al (2014) Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell 56(1):29–42
Sneeringer CJ, Scott MP et al (2010) Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B- cell lymphomas. Proc Natl Acad Sci USA 107(49):20980–20985
Soccio RE, Chen ER et al (2015) Genetic variation determines PPARgamma function and anti-diabetic drug response in vivo. Cell 162(1):33–44
Takahashi H, Parmely TJ et al (2011) Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 146(1):92–104
Thurman RE, Rynes E et al (2012) The accessible chromatin landscape of the human genome. Nature 489(7414):75–82
Tie F, Banerjee R et al (2012) Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27. Mol Cell Biol 32(12):2323–2334
Tuan D, Kong S et al (1992) Transcription of the hypersensitive site HS2 enhancer in erythroid cells. Proc Natl Acad Sci USA 89(23):11219–11223
Van der Meulen J, Sanghvi V et al (2015) The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia. Blood 125(1):13–21
van Haaften G, Dalgliesh GL et al (2009) Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 41(5):521–523
Varambally S, Dhanasekaran SM et al (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419(6907):624–629
Weinstein JN, Collisson EA et al (2013) The cancer genome atlas pan-cancer analysis project. Nat Genet 45(10):1113–1120
Whyte WA, Bilodeau S et al (2012) Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 482(7384):221–225
Wu G, Broniscer A et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44(3):251–253
Yamaguchi H, Hung MC (2014) Regulation and role of EZH2 in cancer. Cancer Res Treat J Korean Cancer Assoc 46(3):209–222
Zaret KS, Carroll JS (2011) Pioneer transcription factors: establishing competence for gene expression. Genes Dev 25(21):2227–2241
Zuin J, Dixon JR et al (2014) Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells. Proc Natl Acad Sci USA 111(3):996–1001
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Luo, Z., Lin, C. (2019). Linking Enhancer to Epigenetics: New Way to Think About Human Diseases. In: Patel, V., Preedy, V. (eds) Handbook of Nutrition, Diet, and Epigenetics. Springer, Cham. https://doi.org/10.1007/978-3-319-55530-0_66
Download citation
DOI: https://doi.org/10.1007/978-3-319-55530-0_66
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55529-4
Online ISBN: 978-3-319-55530-0
eBook Packages: MedicineReference Module Medicine